PYC Therapeutics (PYC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock PYC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period PYC Therapeutics Updates Stakeholders on Business ProgressOctober 12 at 7:51 PM | tipranks.comPYC Therapeutics to Host Investor Webinar on Strategic DevelopmentsSeptember 29, 2025 | tipranks.comPYC Therapeutics Clarifies Trading Halt: Focus on Leadership ChangesSeptember 18, 2025 | tipranks.comPYC Therapeutics Initiates Trading Halt Amidst Strategic ChangesSeptember 18, 2025 | tipranks.comPYC Therapeutics Advances PYC-001 for Blinding Eye DiseaseSeptember 4, 2025 | tipranks.comPYC Therapeutics Reports Financial Results and Increases Stake in Vision PharmaAugust 28, 2025 | tipranks.comPYC Therapeutics Releases 2025 Corporate Governance StatementAugust 28, 2025 | tipranks.comPYC Therapeutics Emphasizes Corporate Governance and Strategic OversightAugust 28, 2025 | tipranks.comPYC Therapeutics Advances Clinical Trials for PKD TreatmentAugust 7, 2025 | tipranks.comPYC Therapeutics Updates Investors in Q3 WebinarJuly 31, 2025 | tipranks.comPYC Therapeutics to Host Investor Webinar on Q3 ProgressJuly 27, 2025 | tipranks.comPYC Therapeutics Advances Clinical Trials for PKD TreatmentJuly 6, 2025 | tipranks.comPYC Therapeutics Advances Phelan-McDermid Syndrome ProgramJune 26, 2025 | tipranks.comPYC Therapeutics Advances VP-001 with FDA Trial Design ApprovalJune 22, 2025 | tipranks.comPYC Therapeutics Advances Clinical Trial for PKD TreatmentMay 25, 2025 | tipranks.comPYC Therapeutics Unveils Promising Trial Results for Retinitis Pigmentosa TreatmentMay 1, 2025 | tipranks.comPYC Therapeutics Reports Positive Clinical Trial Results for Eye Disease TreatmentApril 27, 2025 | tipranks.comPYC Therapeutics Secures $146 Million in Entitlement Offer to Advance RNA TherapiesApril 16, 2025 | tipranks.comPYC Therapeutics Advances PYC-003 in Polycystic Kidney Disease TrialApril 9, 2025 | tipranks.comPYC Therapeutics Secures Majority of Entitlement Offer Amid Underwriter DelaysApril 8, 2025 | tipranks.comPYC Therapeutics Updates Investors on Business ProgressMarch 27, 2025 | tipranks.comBuy Rating for PYC Therapeutics: Promising Pipeline and Market Position in Genetic MedicineMarch 25, 2025 | tipranks.comPYC Therapeutics Launches Retail Entitlement Offer to Fund RNA Therapy DevelopmentFebruary 23, 2025 | tipranks.comPYC Therapeutics Launches $146 Million Entitlement OfferFebruary 23, 2025 | tipranks.comPYC Therapeutics to Raise $146 Million for Drug Pipeline AdvancementFebruary 16, 2025 | tipranks.comPYC Therapeutics Launches Equity Raising to Bolster Financial PositionFebruary 16, 2025 | tipranks.comPYC Therapeutics to Issue 116.6 Million Securities in Accelerated OfferFebruary 16, 2025 | tipranks.comPYC Therapeutics Launches A$145.8 Million Entitlement OfferFebruary 16, 2025 | tipranks.comPYC Therapeutics Gains Approval for PKD Drug Human TrialsFebruary 9, 2025 | tipranks.comPYC Therapeutics Secures FDA Rare Disease Designation for VP-001January 19, 2025 | tipranks.comPYC Therapeutics Updates on Kidney Disease ResearchNovember 27, 2024 | tipranks.comPYC Therapeutics Expands Employee Incentive OptionsNovember 27, 2024 | tipranks.comPYC Therapeutics Advances Kidney Disease Drug TrialsNovember 26, 2024 | tipranks.comUS FDA DESIGNATES PYC'S LEAD AS A FAST TRACK DEVELOPMENT PROGRAMAugust 11, 2023 | finance.yahoo.comPYC.AX - PYC Therapeutics LimitedJuly 24, 2023 | au.finance.yahoo.comASX Health Stocks: Successful toxicology tests pave the way for PYC’s Phase 2 clinical trialJuly 17, 2023 | msn.comNon-Executive Chair of the Board of PYC Therapeutics Alan Tribe Buys 26% More SharesJuly 15, 2023 | finance.yahoo.comASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTATMarch 5, 2023 | msn.comOwning 50% in PYC Therapeutics Limited (ASX:PYC) means that insiders are heavily invested in the company's futureJanuary 13, 2023 | finance.yahoo.comPYC Therapeutics Limited (ASX:PYC) insider upped their holding by 0.2% earlier this yearDecember 23, 2022 | nz.finance.yahoo.comWill PYC Therapeutics (ASX:PYC) Spend Its Cash Wisely?November 21, 2022 | finance.yahoo.comPYC Therapeutics Limited (PYC.AX)September 14, 2022 | finance.yahoo.comPYC Therapeutics LtdAugust 16, 2022 | reuters.comAHF Sounds ‘Monkeypox: LA County Alert’ in Latest LA Times AdAugust 8, 2022 | nz.finance.yahoo.comBond Traders on Collision Course With Fed Over Longer-Term ViewAugust 8, 2022 | nz.finance.yahoo.comWe're Hopeful That PYC Therapeutics (ASX:PYC) Will Use Its Cash WiselyJune 7, 2022 | finance.yahoo.comThose who invested in PYC Therapeutics (ASX:PYC) three years ago are up 256%May 9, 2022 | finance.yahoo.comHow to Increase the Competitive Advantage of Your Small to Midsize BusinessMarch 2, 2022 | news.yahoo.comKillearn Golf & Country Club on verge of new ownership, 'massive revitalization' on horizonMarch 1, 2022 | news.yahoo.comWhat Is The Ownership Structure Like For PYC Therapeutics Limited (ASX:PYC)?February 27, 2022 | finance.yahoo.com Get PYC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PYC Media Mentions By Week PYC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PYC News Sentiment▼-0.300.72▲Average Medical News Sentiment PYC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PYC Articles This Week▼10▲PYC Articles Average Week Get the Latest News and Ratings for PYC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for PYC Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GNS News Today ONC News Today ONT News Today BIO News Today OXB News Today HBP News Today FRX News Today PRTC News Today AVCT News Today TH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:PYC) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PYC Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share PYC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
